entertainment -WSS

entertainment

author：comprehensive 2025-09-09 05:35:27 - browse：5

There’s a pharmacy in the White House — or, at least, there’s a sign that says “Pharmacy,” though the people in charge insist it isn’t one. Whatever they call it, the office has had enough internal complaints to warrant a government watchdog investigation.

And its findings were hardly encouraging:

One former pharmacy staff member told investigators that a doctor once asked if the staffer could “hook up” someone with a controlled substance “as a parting gift for leaving the White House.”
The office dispensed controlled medications like Ambien and Provigil without verifying the patient’s identity.
It let people grab over-the-counter medicines from open bins.
And upwards of $640,000 in taxpayer funds were wasted in just three years, though that number is fuzzy, because so many records were poorly kept and even handwritten.

The investigation, published this month, was conducted by the Department of Defense’s independent Office of the Inspector General; the White House pharmacy is run by the White House Military Office and its associated medical unit. The probe was prompted by complaints the Department of Defense received in 2018 about a senior military medical officer, who is not named, engaging in “improper medical practices.” It covers only activity in the office through early 2020 under the Trump administration, but investigators interviewed staffers who also worked there under former President Obama.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： A virus, fished out of a lake, may have saved a man’s life

explore

WSS

Was Amgen transparent enough on FDA's concern on cancer drug?

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Senate panel eyes new effort on drug shortages

Popular nasal decongestant doesn't actually relieve congestion

New weight loss drugs vying to be the next Wegovy or Mounjaro

Phenylephrine and the overlooked value of the placebo effect

hotspot

entertainment

focus

In age of alternative facts, a scholarly course on calling out crap

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Food makers tried to stack nutrition panel with preferred experts

United colonoscopy coverage change 'may cost lives,' doctors say

A virus, fished out of a lake, may have saved a man’s life

Medical records are filled with copy

Regeneron agrees to White House price limits on anti

Psychedelics group wrestles with new pharma identity

Physician executives need more than on

focus

White House touts steps to stem shortages of cancer treatments

Pig kidney works a record two months in donated body

IRA could hurt research into orphan drugs for rare diseases

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Chemotherapy drug shortage eases slightly but still widespread

Senate panel eyes new effort on drug shortages

entertainment

explore

focus

focus